Literature DB >> 11870013

Combined pharmacotherapy and psychotherapy as maintenance treatment for late-life depression: effects on social adjustment.

Eric J Lenze1, Mary Amanda Dew, Sati Mazumdar, Amy E Begley, Cleon Cornes, Mark D Miller, Stanley D Imber, Ellen Frank, David J Kupfer, Charles F Reynolds.   

Abstract

OBJECTIVE: This study examined the effects of maintenance treatment for late-life depression on social adjustment. The authors hypothesized that elderly patients recovering from depression would have better social adjustment with medication and interpersonal psychotherapy than with medication or psychotherapy alone.
METHOD: Patients aged 60 and older recovering from recurrent major depression were randomly assigned to one of four treatments: nortriptyline and interpersonal psychotherapy, nortriptyline and clinic visits, placebo and psychotherapy, or placebo and clinic visits. The Social Adjustment Scale was administered every 3 months until illness recurrence. Combined treatment was compared to monotherapy on scores over 1 year among patients who remained in recovery (N=49).
RESULTS: Patients receiving nortriptyline and interpersonal psychotherapy maintained social adjustment, which declined in those receiving monotherapy.
CONCLUSIONS: Treatment of late-life depression with nortriptyline and psychotherapy is more likely to maintain social adjustment than treatment with either alone. Combination therapy improves not only duration but quality of wellness.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11870013     DOI: 10.1176/appi.ajp.159.3.466

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  18 in total

1.  Genetic moderation of interpersonal psychotherapy efficacy for low-income mothers with major depressive disorder: implications for differential susceptibility.

Authors:  Dante Cicchetti; Sheree L Toth; Elizabeth D Handley
Journal:  Dev Psychopathol       Date:  2015-02

2.  Longitudinal social-interpersonal functioning among higher-risk responders to acute-phase cognitive therapy for recurrent major depressive disorder.

Authors:  Jeffrey R Vittengl; Lee Anna Clark; Michael E Thase; Robin B Jarrett
Journal:  J Affect Disord       Date:  2016-04-13       Impact factor: 4.839

Review 3.  Treatment of depression in older adults.

Authors:  Cássio M C Bottino; Ricardo Barcelos-Ferreira; Salma R I Ribeiz
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

4.  Adapting interpersonal psychotherapy for older adults at risk for suicide.

Authors:  Marnin J Heisel; Nancy L Talbot; Deborah A King; Xin M Tu; Paul R Duberstein
Journal:  Am J Geriatr Psychiatry       Date:  2014-03-29       Impact factor: 4.105

5.  Domain-specific social functioning improvements during treatment of depressed women with histories of childhood sexual abuse.

Authors:  Stephanie A Gamble; Phillip N Smith; Ellen L Poleshuck; Hua He; Nancy L Talbot
Journal:  J Affect Disord       Date:  2010-11-03       Impact factor: 4.839

6.  Using the Interpersonal Theory of Suicide to Inform Interpersonal Psychotherapy with a Suicidal Older Adult.

Authors:  Kimberly A Van Orden; Nancy Talbot; Deborah King
Journal:  Clin Case Stud       Date:  2012-08-30

7.  Treatment of late-life depression alleviates caregiver burden.

Authors:  Lynn M Martire; Richard Schulz; Charles F Reynolds; Jordan F Karp; Ariel G Gildengers; Ellen M Whyte
Journal:  J Am Geriatr Soc       Date:  2009-11-25       Impact factor: 5.562

Review 8.  Adherence to depression treatment in older adults: a narrative review.

Authors:  Kara Zivin; Helen C Kales
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 9.  Psychiatric epidemiology: challenges and opportunities.

Authors:  Ronald C Kessler
Journal:  Int Rev Psychiatry       Date:  2007-10

10.  [Neurobiological subtypes of geriatric depression. Their importance for diagnosis and treatment].

Authors:  M A Rapp
Journal:  Z Gerontol Geriatr       Date:  2013-02       Impact factor: 1.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.